Delivery Order SPE2DB24D1201-SPE2DB25FJCLS

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,121.28 and a period of performance through December 30, 2024. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a $1,318.99 ceiling value and covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract has a firm fixed price pricing type and a completion...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of a variety of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies and equipment. The contract has a ceiling value of $16,503.50 and a performance period ending on July 30, 2024. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a comprehensive range of pharmaceutical products, medical supplies, prescription medications, vaccines, and medical equipment to support military healthcare programs globally. The contract has a ceiling value of $25,101.76 and an ultimate completion date of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract has a ceiling value of $1,279.17 and a performance period ending on September 14, 2023....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $804,694.27 and is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00,...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The delivery order has a ceiling value of $63,008.40 and is for the procurement of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract has a ceiling value of $746,584.26 and a completion date of October 19, 2023. It is a firm-fixed-price contract for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's existing Indefinite Delivery Contract (IDC) with DLA valued at $999,999,999.00. The delivery order has a ceiling value of $730,597.75 and a period of performance through May 24, 2024. It is a firm-fixed-price contract for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,139.61 and a period of performance through April 28, 2025. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJCLS
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical and medical products, including a variety of prescription medications and specialized medical supplies. The contract has a ceiling value of $8,007.09 and a period of performance through April 30, 2025. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. The products being delivered under this contract span multiple therapeutic areas, such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, antibiotics, and specialized medical supplies, supporting the medical procurement needs of the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 7/29/25, 9:46 AM